{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:09:12Z","timestamp":1794874152067,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Oral and Dental Research Trust","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-communicable diseases [NCDs] are the major cause of mortality globally and are increasing in prevalence. Different healthcare professionals\u2019 access different population groups; and engaging allied healthcare professionals in risk-driven early case detection of certain NCDs may be beneficial, especially those who have not been tested for NCDs within the previous 12\u2009months.<\/jats:p>\n                    <jats:p>The objectives of this study were to determine: whether NCD case finding in dental\/community pharmacy settings is feasible in terms of patient acceptability, barriers to recruitment, impact on the existing service. Determine time taken to test for: type 2 diabetes risk [T2DM], chronic obstructive pulmonary disease [COPD], hypertension, vitamin D deficiency and chronic kidney disease [CKD]. Determine whether there is added benefit of point of care testing [POCT] to identify diabetes risk compared to a validated screening questionnaire alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An exploratory study was undertaken to explore issues associated with NCD assessment in one dental practice and one community pharmacy within the West-Midlands, UK. Fifty patients &gt;\u200940\u2009years-of-age were recruited per site. Participants undertook: a questionnaire providing demographic data, any previous NCD diagnosis or positive family history. Validated questionnaires for determining NCD risk [T2DM\/COPD]. Chair-side capillary blood [finger-prick] samples for HbA1C, creatinine\/eGFR, Vitamin-D.<\/jats:p>\n                    <jats:p>Prior work had been undertaken to measure the agreement between point of care testing [POCT] devices and a central laboratory method, and to gauge the opinions of participants regarding discomfort experienced using venous (antecubital fossa) and capillary (finger-prick) blood collection, via a 10\u2009cm Visual-Analogue-Scale. The POCT devices demonstrated good concordance with laboratory testing and were acceptable methods of blood collection for participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recruitment rates demonstrated that 8\u2009days were needed to recruit 50 participants and 60% of those approached opted to participate. The principal barrier to participation was time, with average time taken to test being 19mins. Utilising dental and pharmacy settings identified potential cases of previously undiagnosed disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Risk-targeted testing for NCDs in high street dental and community pharmacies is both attractive and acceptable to patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-020-09649-7","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T08:03:58Z","timestamp":1603181038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5477-8315","authenticated-orcid":false,"given":"Zehra","family":"Yonel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Yahyouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain L. C.","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"9649_CR1","unstructured":"National Council on Aging. [18th June 2020]; Available from: https:\/\/www.ncoa.org\/news\/resources-for-reporters\/get-the-facts\/healthy-aging-facts\/?print=t."},{"issue":"4","key":"9649_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/pubmed\/fdr033","volume":"33","author":"P Scarborough","year":"2011","unstructured":"Scarborough P, Bhatnagar P, Wickramasinghe KK, Allender S, Foster C, Rayner M. The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs. J Public Health. 2011;33(4):527\u201335.","journal-title":"J Public Health"},{"key":"9649_CR3","doi-asserted-by":"publisher","unstructured":"Yonel Z, Sharma P, Yahyouche A, Jalal Z, Dietrich T, Chapple IL. Patients\u2019 attendance patterns to different healthcare settings and perceptions of stakeholders regarding screening for chronic, non-communicable diseases in high street dental practices and community pharmacy: a cross-sectional study. BMJ Open. 2018;8(11):e024503. https:\/\/doi.org\/10.1136\/bmjopen-2018-024503. PMID: 30391921; PMCID: PMC6231598.","DOI":"10.1136\/bmjopen-2018-024503"},{"issue":"1","key":"9649_CR4","first-page":"76","volume":"4","author":"C Estrich","year":"2019","unstructured":"Estrich C, Araujo MWB, Lipman R. Prediabetes and Diabetes screening in dental care settings: NHANES 2013 to 2016. JDR Clin Trans Res. 2019;4(1):76\u201385.","journal-title":"JDR Clin Trans Res"},{"issue":"2","key":"9649_CR5","first-page":"156","volume":"70","author":"SM Strauss","year":"2010","unstructured":"Strauss SM, Russell S, Wheeler A, Norman R, Borrell LN, Rindskopf D. The dental office visit as a potential opportunity for diabetes screening: an analysis using NHANES 2003-2004 data. J Public Health Dent. 2010;70(2):156\u201362.","journal-title":"J Public Health Dent"},{"issue":"11","key":"9649_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.bdj.2012.1088","volume":"213","author":"DA White","year":"2012","unstructured":"White DA, Tsakos G, Pitts NB, Fuller E, Douglas GVA, Murray JJ, et al. Adult dental health survey 2009: common oral health conditions and their impact on the population. Br Dent J. 2012;213(11):567\u201372.","journal-title":"Br Dent J"},{"key":"9649_CR7","unstructured":"Wiedenmayer K, Summers RS, Mackie CA, Gous AGS, Everard M, Tromp D, et al. Developing pharmacy practice : a focus on patient care : handbook. Geneva : World Health Organization: WHO; 2006."},{"key":"9649_CR8","unstructured":"Smith J, Picton C and Dayan M (2014) Now more than ever: why pharmacy needs to act. [June 18, 2020] Available from: https:\/\/www.nuffieldtrust.org.uk\/research\/now-more-than-ever-why-pharmacy-needs-to-act."},{"key":"9649_CR9","unstructured":"NHS England. Five year forward view. 2014. [June, 18th 2020] Available from: https:\/\/www.england.nhs.uk\/five-year-forward-view\/."},{"key":"9649_CR10","unstructured":"Roland M. The future of Primary Care: creating teams for tomorrow. Leeds: Health Education England. Primary Care Workforce Commission: 2015. [June, 18th 2020] Available from: https:\/\/www.hee.nhs.uk\/our-work\/primary-care-workforce-commission."},{"key":"9649_CR11","unstructured":"National Instititute for Health and Care Excellence. NICE Public Health Guidance [PH38] type 2 diabetes: prevention in people at high risk. 2017. Webpage. [June 18th, 2020] Available from: https:\/\/www.nice.org.uk\/guidance\/ph38\/chapter\/recommendations#recommendation-3-risk-identification-stage-1."},{"key":"9649_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2017.12.001","volume":"137","author":"M Sanz","year":"2018","unstructured":"Sanz M, Ceriello A, Buysschaert M, Chapple IL, Demmer RT, Graziani F, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and by the international Diabetes federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018;137:231\u201341.","journal-title":"Diabetes Res Clin Pract"},{"key":"9649_CR13","unstructured":"Public Health England NEaHEE. Pharmacy: A Way Forward for Public Health. Opportunities for action through pharmacy for public health. Public Health England: 2017 Acessed: [June 6th, 2020]. Ref: PHE publications gateway number 2017212. Available from: https:\/\/www.gov.uk\/government\/publications\/community-pharmacy-public-health-interventions."},{"issue":"1","key":"9649_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bcp.14164","volume":"86","author":"AA Alshehri","year":"2020","unstructured":"Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: a systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29\u201338.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"9649_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1345\/aph.1E504","volume":"39","author":"DA Sicard","year":"2005","unstructured":"Sicard DA, Taylor JR. Comparison of point-of-care HbA1c test versus standardized laboratory testing. Ann Pharmacother. 2005;39(6):1024\u20138.","journal-title":"Ann Pharmacother"},{"issue":"11","key":"9649_CR16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.5858\/arpa.2011-0157-RA","volume":"135","author":"K Lewandrowski","year":"2011","unstructured":"Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch Pathol Lab Med. 2011;135(11):1405\u201314.","journal-title":"Arch Pathol Lab Med"},{"key":"9649_CR17","unstructured":"Cals JW, Schols AM, van Weert HC, Stevens F, Zeijen CG, Holtman G, et al. Point-of-care testing in family practices: present use and need for tests in the future. Nederlands tijdschrift voor geneeskunde, 2014;158:A8210."},{"issue":"6","key":"9649_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1365-2141.2008.07274.x","volume":"142","author":"C Briggs","year":"2008","unstructured":"Briggs C, Guthrie D, Hyde K, Mackie I, Parker N, Popek M, et al. Guidelines for point-of-care testing: haematology. Br J Haematol. 2008;142(6):904\u201315.","journal-title":"Br J Haematol"},{"issue":"7","key":"9649_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1464-5491.2007.02175.x","volume":"24","author":"MA Stone","year":"2007","unstructured":"Stone MA, Burden AC, Burden M, Baker R, Khunti K. Near patient testing for glycated haemoglobin in people with type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabet Med. 2007;24(7):792\u20135.","journal-title":"Diabet Med"},{"issue":"1","key":"9649_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/135581960000500109","volume":"5","author":"B Delaney","year":"2000","unstructured":"Delaney B, Wilson S, Fitzmaurice D, Hyde C, Hobbs R. Near-patient tests in primary care: setting the standards for evaluation. J Health Serv Res Pol. 2000;5(1):37\u201341.","journal-title":"J Health Serv Res Pol"},{"key":"9649_CR21","unstructured":"Diabetes UK, the University of Leicester and the University Hospital of Leicester NHS Trust. Diabetes Risk Score. Diabetes UK, the University of Leicester and the University Hospital of Leicester NHS Trust; [25\/09\/2020]; Available from: https:\/\/riskscore.diabetes.org.uk\/start."},{"issue":"2","key":"9649_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/15412550801940721","volume":"5","author":"FJ Martinez","year":"2008","unstructured":"Martinez FJ, Raczek AE, Seifer FD, Conoscenti CS, Curtice TG, D\u2019Eletto T, et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD: Int J Chron Obstruct Pulmon Dis. 2008;5(2):85\u201395.","journal-title":"COPD: Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"9649_CR23","first-page":"57","volume":"145","author":"RJ Genco","year":"2014","unstructured":"Genco RJ, Schifferle RE, Dunford RG, Falkner KL, Hsu WC, Balukjian J. Screening for diabetes mellitus in dental practices a field trial. JADA. 2014;145(1):57\u201364.","journal-title":"JADA"},{"issue":"3","key":"9649_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/jcpe.12358","volume":"42","author":"E Lalla","year":"2015","unstructured":"Lalla E, Cheng B, Kunzel C, Burkett S, Ferraro A, Lamster IB. Six-month outcomes in dental patients identified with hyperglycaemia: a randomized clinical trial. J Clin Periodontol. 2015;42(3):228\u201335.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"9649_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.2013.1247","volume":"216","author":"S Creanor","year":"2014","unstructured":"Creanor S, Millward BA, Demaine A, Price L, Smith W, Brown N, et al. Patients' attitudes towards screening for diabetes and other medical conditions in the dental setting. Br Dent J. 2014;216(1):E2.","journal-title":"Br Dent J"},{"key":"9649_CR26","doi-asserted-by":"crossref","unstructured":"Yonel Z, Cerullo E, Kr\u00f6ger AT, Gray LJ. Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia: a systematic review. Diabet Med. 2020;19.","DOI":"10.1111\/dme.14324"},{"key":"9649_CR27","doi-asserted-by":"crossref","unstructured":"Yonel Z, Batt J, Jane R, Cerullo E, Gray LJ, Dietrich T, et al. The Role of the Oral Healthcare Team in Identification of Type 2 Diabetes Mellitus: A Systematic Review. Curr. Oral Health Rep. 2020 2020\/01\/18.","DOI":"10.1007\/s40496-020-00250-w"},{"key":"9649_CR28","doi-asserted-by":"crossref","unstructured":"Bould K, Scott SE, Dunne S, Asimakopoulou K. Uptake of screening for type 2 diabetes risk in general dental practice; an exploratory study. Br. Dent.. 2017 02\/24\/online;222:293.","DOI":"10.1038\/sj.bdj.2017.174"},{"key":"9649_CR29","unstructured":"Public Health England NEaHEE. Public Health Matters. 2020 [June 6th, 2020]; Available from: https:\/\/publichealthmatters.blog.gov.uk\/2019\/06\/28\/pharmacy-playing-a-pivotal-role-in-prevention-and-public-health\/."},{"key":"9649_CR30","unstructured":"NHS. Longterm Plan. [June 6th, 2020]; Available from: https:\/\/www.longtermplan.nhs.uk\/."},{"key":"9649_CR31","unstructured":"National Instititute for Health and Care Excellence. NICE Public Health Guidance [PH38] type 2 diabetes: Encouraging people to have a risk-assessment for type 2 diabetes and identifying those at risk. 2017. [June 6th, 2020]. Available from: https:\/\/www.nice.org.uk\/guidance\/ph38."},{"key":"9649_CR32","doi-asserted-by":"crossref","unstructured":"Waugh NR, Shyangdan, D, Taylor-Phillips S, Suri G, Hall B. Screening for type 2 diabetes: a short report for the National Screening Committee. Health Technology Assessment (Winchester, England), Volume 17 (Number 35). pp. 1\u201390.","DOI":"10.3310\/hta17350"}],"updated-by":[{"DOI":"10.1186\/s12889-021-10303-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000}}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-09649-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T19:58:52Z","timestamp":1634673532000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9649"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09649-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12889-021-10303-z","URL":"https:\/\/doi.org\/10.1186\/s12889-021-10303-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics committee approval was sought and granted from the Coventry and Warwickshire ethics committee and the University of Birmingham was the study sponsor (RG_16\u2013102). Written consent for participation was obtained from all participants.West Midlands \u2013 Coventry and Warwickshire Research Ethics CommitteeREC reference: 17\/WM\/\/0022Protocol number: RG_16\u2013102IRAS project ID:200232","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1576"}}